SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318771-06-000025
Filing Date
2006-08-03
Accepted
2006-08-02 20:47:25
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. FORM 10-Q FOR THE PERIOD ENDED 06/30/2006 dna-10q_0206.htm 10-Q 1358902
2 AMENDED AND RESTATED COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND IDEC PH ex10_2.htm EX-10.2 630111
3 LETTER AMENDMENT DATED AS OF AUGUST 21, 2003, TO THE AMENDED AND RESTATED COLLAB ex10_3.htm EX-10.3 14735
4 LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION. ex15_1.htm EX-15.1 5882
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_1.htm EX-31.1 12958
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( ex31_2.htm EX-31.2 13150
7 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T ex32_1.htm EX-32.1 11924
  Complete submission text file 0000318771-06-000025.txt   2049054
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-09813 | Film No.: 06999606
SIC: 2834 Pharmaceutical Preparations